To Evaluate the Safety and Effectiveness of Intrauterine Adhesion Preventer in the Prevention and Treatment of Intrauterine Adhesions, a Prospective, Multicenter, Randomized Controlled Clinical Trial

Inclusion Criteria:

• Patients clinically diagnosed with intrauterine adhesions and with surgical indications (referring to those with fertility requirements or obstructed menstrual blood drainage) ② Women aged 20-40 years old; ③ Subjects voluntarily participated in the trial and signed informed consent.

Exclusion Criteria:

• ① Patients with obviously abnormal uterine cavity shape after surgery; those who could not clearly separate the normal uterine cavity anatomical morphology (i.e. bilateral or unilateral fallopian tube openings were not visible); those with reproductive organ malformations and uterine cavities that were too large or too small; those with recent uterine perforation; those with cervical insufficiency.

  • Those with a history of intrauterine adhesions and treatment;

    • Those with endometrial tuberculosis or suspected endometrial tuberculosis;

      • Those with adenomyosis or uterine fibroids>4cm;

        • Those with a history of malignant tumors or suspected malignant tumors;

          • Those with acute and chronic intrauterine infection and genital infection;

            • Those with unexplained vaginal bleeding or suspected uterine malignant lesions;

              • Those with severe anemia and abnormal coagulation function; those with a history of thrombosis; ⑨ Those in the acute stage of various diseases or severe systemic diseases;

                • Those with severe mental illness and physical weakness who cannot tolerate this operation;

                  ⑪ Those with severe heart, liver, and kidney function diseases;

                  ⑫ Those with contraindications to anesthesia or surgery;

                  ⑬ Those who have participated in clinical trials in the past three months.

                  • Those who are considered unsuitable for inclusion by the researchers.